Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep657 | Female Reproduction | ECE2016

Immunity to Haemophilus influenzae B and Peumococcal vaccination among adult women with Turner Syndrome

Bukowczan Jakub , Liew Aaron , Roberts Graham , Spickett Gavin , Quinton Richard

Introduction: Turner Syndrome (TS) is associated with a higher overall morbidity and mortality than the general population, with respiratory diseases as one of the major causes. Haemophilus influenza type B (HiB) and pneumococcal (PC) vaccination can reduce morbidity and mortality, by alleviating the risk of respiratory diseases. All patients in the Newcastle Adult Turner Syndrome clinic who lack immunity to either HiB or PC at baseline receive vaccination in our TS clinic. Ho...

ea0037ep250 | Calcium and Vitamin D metabolism | ECE2015

High offset point for normocalcaemic secondary hyperparathyroidism due to vitamin D deficiency

Gulfam Taimur , Aggarwal Naveen , Ganguri Murali , Quinton Richard

Introduction: Vitamin D deficiency occurs more frequently in patients with primary hyperparathyroidism compared to general population, and is usually associated with an aggravated form of the disease. Current guidelines recommend measurement of vitamin D level in all patients with primary hyperparathyroidism, and their repletion if the levels are <50 nmol/l.Case report: We present a 56 years old Caucasian lady who underwent right parathyroidectomy &#...

ea0035n4 | (1) | ECE2014

Adherence to treatment for chronic hypogonadism: the role of illness perceptions and depressive symptoms

Dwyer Andrew , Tiemensma Jitske , Quinton Richard , Morin Diane , Pitteloud Nelly

Background: For chronic diseases, adherence to treatment remains a major clinical challenge. For men with long-term hypogonadism, there is scant data regarding adherence to treatment. Congenital hypogonadotropic hypogonadism (CHH) is a rare, genetic, endocrine disorder characterized by incomplete/absent puberty and infertility. Little is known about adherence in this patient population or the psychosocial implications of living with this rare disorder. Therefore, we aimed to e...

ea0035p847 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2014

TSH-secreting pituitary adenoma treated conservatively with cabergoline for more than 10 years

Mathiopoulou Monika , Bukowczan Jakub , Lois Konstantinos , Quinton Richard

Background: TSH secreting pituitary adenomas represent small proportion of functional pituitary tumours presenting as hyperthyroidism with elevated thyroid hormone levels and inappropriately normal or increased TSH concentration. They are ≥1 cm in size and quite aggressive with tendency to relapse following transphenoidal adenomectomy (TSA). Surgical resection remains gold standard in their definitive treatment while pharmacotherapy with long-acting somatostatin analogue...

ea0034p91 | Clinical practice/governance and case reports | SFEBES2014

Kallmann syndrome, gender dysphoria, thrombophilia and multiple sclerosis: a complex case report

Renukanthan Aniruthan , Quinton Richard , Turner Ben , Korbonits Marta

A 34-year-old male with two decades of gender identity issues considered gender reassignment and attended pre-orchidectomy sperm-banking when he was found to be azoospermic. He described a history of difficulty learning to play the piano and of deep-vein thrombosis at 19 years. He was 187 cm tall with a span of 189.7 cm, and exhibited L-sided undescended testis, R testis 1.8×2.5×3.7 cm, bilateral prominent gynaecomastia, a female body habitus, micropenis, bimanual sy...

ea0028p39 | Clinical practice/governance and case reports | SFEBES2012

A UK epidemic of testosterone prescribing 2000–2010: ‘Never mind the testes’

Gan Earn , Pattman Stewart , Quinton Richard , Pearce Simon

Male hypogonadism is characterised by sexual dysfunction, loss of muscle bulk, central obesity, fatigue, mood and sleep disturbances, osteoporosis and anaemia. Although these features are associated with low serum testosterone concentration, not all men with a low serum testosterone are definitively hypogonadal, and there is a large symptom overlap with obesity and non-endocrine illness. Importantly, testosterone replacement therapy may not be appropriate for men with mild, fu...

ea0010p65 | Reproduction | SFE2005

PCOS responsive to metformin therapy despite very low BMI

Thomas R , Woods D , Michael E , Quinton R

Clinical CaseA 19-year old ethnic Pakistani presented with severe, longstanding hirsutes without virilisation. Menarche had occurred at age 14, following which she had experienced 4-6 periods a year. She had always been “underweight” by UK/WHO criteria and, given a BMI of 16.5 kg.m−2, there were concerns about hypothalamic oligomenorrhoea.InvestigationsFasting glucose 5.5 mmol/L &#...

ea0002p12 | Clinical case reports | SFE2001

Severe hyperandrogenism with polycythaemia: use of metformin as a therapeutic and diagnostic tool

Senior P , Ball S , Baylis P , Quinton R

Polycystic ovarian syndrome (PCOS) is the commonest cause of hyperandrogenism in women. Severe hyperandrogenism or virilisation, however, suggest the need to consider rarer causes e.g. Cushing's, congenital adrenal hyperplasia and androgen-secreting tumours. Here we present a case of PCOS where the remarkable response of severe hyperandrogenism with polycythaemia to metformin excluded these rarer causes without the need for complex or invasive investigation.<p class="abste...

ea0077op5.3 | Bone and Calcium | SFEBES2021

Vitamin D deficiency is highly prevalent among patients who died from COVID-19 in the North-East of England.

Motohashi Kenzo , Ann Tee Su , Echevarria Carlos , Burns Graham , Quinton Richard

Background: Vitamin D deficiency (VDD) has been implicated in the pathophysiology of respiratory infections, including Coronavirus Disease 2019 (COVID-19). We assessed vitamin D levels of patients who died from COVID-19 during or following admission to Newcastle-upon-Tyne Hospitals.Methods: We performed a retrospective survey of electronic patient records for 2,355 patients admitted to our institution between 04/02/2020 and 19/01/2021, who had a positive...

ea0081p191 | Reproductive and Developmental Endocrinology | ECE2022

FSH and bone: comparison between males with central vs primary hypogonadism

Giovanelli Luca , Cangiano Biagio , Colombo Stefano , Persani Luca , Quinton Richard , Bonomi Marco , Chiodini Iacopo

Background: Recent data suggest a direct effect of follicle stimulating hormone (FSH) on the skeletal metabolism. Particularly, it can encourage bone resorption and also inhibit osteoblast differentiation. High FSH levels have been found to correlate with impaired bone health in females, whilst evidence in males remains somewhat poor and conflicting. Intriguingly, men with primary and central hypogonadism might represent a novel study model in this context.<p class="abstex...